Search results for " Phase"

showing 10 items of 1862 documents

Outcome of LR-3 and LR-4 observations without arterial phase hyperenhancement at Gd-EOB-DTPA-enhanced MRI follow-up

2020

Objective: The aim of this study was to retrospectively analyze the outcome of LR-3 and LR-4 without arterial phase hyperenhancement (APHE), and identify which features could predict LR-5 progression on serial Gd-EOB-DTPA-enhanced MRI follow-up. Methods: Forty-nine cirrhotic patients with 55 LR-3 and 19 LR-4 without APHE were evaluated. Observations were classified as decreased, stable or increased in category at follow-up. Observation size and LI-RADS major and ancillary features were evaluated. Results: Seventeen/fifty-five (31%) LR-3 and 8/19 (42%) LR-4 progressed to LR-5 at follow-up. Baseline LI-RADS major and ancillary features were not significantly different among LR-3 and LR-4. A d…

Gadolinium DTPAGd-EOB-DTPA-enhanced MRILR-3Carcinoma HepatocellularLR-4business.industryLiver NeoplasmsGd-EOB-DTPAContrast MediaMagnetic Resonance Imaging030218 nuclear medicine & medical imagingSettore MED/01 - Statistica Medica03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMedicineHumansLI-RADSRadiology Nuclear Medicine and imagingNuclear medicinebusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaArterial phaseFollow-Up StudiesRetrospective Studies
researchProduct

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

2015

Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.

Gadolinium DTPALiver CirrhosisGadoxetic acidCirrhotic livermedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisCarcinoma HepatocellularGadoxetic acidContrast MediaGastroenterology030218 nuclear medicine & medical imagingResection03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansIn patientTopic HighlightSettore MED/12 - GastroenterologiaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyHepatobiliary contrast materialMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSettore MED/18 - Chirurgia GeneraleLiver030220 oncology & carcinogenesisHepatobiliary phaseLiver functionSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessCirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging; Gastroenterologymedicine.drugWorld journal of gastroenterology
researchProduct

Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?

2020

Purpose: To compare the level of parenchymal and portal venous enhancement in the portal venous phase (PVP) in cirrhotic patients undergoing gadoxetate disodium- and gadobenate dimeglumine-enhanced MRI. Methods: In this retrospective study, 84 cirrhotic patients (mean age ± SD: 66 ± 13 years) who underwent contrast-enhanced MRI with both gadoxetate disodium and gadobenate dimeglumine between 2012 and 2018 were included. Two readers measured signal intensities of hepatic parenchyma, portal vein and psoas muscle on precontrast and PVP. Relative enhancement (RE), image contrast, and portal vein-to-liver contrast difference were calculated. Intraindividual differences were compared with the Wil…

Gadolinium DTPALiver Cirrhosismedicine.medical_specialtyCirrhosisUrologyPortal veinContrast MediaPortal venous phase030218 nuclear medicine & medical imagingGadoxetate Disodium03 medical and health sciences0302 clinical medicinePrecontrastMeglumineInternal medicineGadobenate dimegluminemedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingGADOBENATE DIMEGLUMINEAgedRetrospective StudiesCirrhosis Portal vein Gadobenate dimeglumine Gadoxetate disodium Hepatic parenchymaHepatic parenchymaRadiological and Ultrasound Technologybusiness.industryGastroenterologyHepatologyMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingCirrhosisHepatic parenchyma030220 oncology & carcinogenesisPortal veinGadoxetate disodiumNuclear medicinebusiness
researchProduct

Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation.

2019

Purpose: To investigate the clinical implications and natural history of observations showing a “nodule-in-nodule” architecture on hepatobiliary phase (HBP) in a cirrhotic population. Method: This is an IRB-approved retrospective study conducted in a single institution. We identified 20 patients (11 men and 9 women, mean age 71 years, range 51–83 years) who had a hyperintense nodule on HBP arising within a larger HBP-hypointense nodule without arterial phase hyperenhancement (APHE) at gadoxetate disodium-enhanced MRI. Size and signal intensity of the nodules were evaluated in all sequences, along with the evolution of the nodules at serial MRI studies. Results: Twenty-four…

Gadolinium DTPAMaleCarcinoma HepatocellularHepatocellular carcinomaPopulationContrast MediaNodule-in-nodule030218 nuclear medicine & medical imagingHepatobiliary phaseGadoxetate Disodium03 medical and health sciences0302 clinical medicineMedicineHumansRadiology Nuclear Medicine and imagingeducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryLiver NeoplasmsWashoutMagnetic resonance imagingNodule (medicine)General MedicineMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingHyperintensityLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaHepatobiliary phaseFemaleGadoxetate disodiummedicine.symptombusinessNuclear medicineHumanEuropean journal of radiology
researchProduct

Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA

2019

Abstract Purpose To compare magnetic resonance imaging (MRI) findings with gadoxetic acid and gadobenate dimeglumine for the diagnosis of hepatic hemangiomas. Materials and Methods In this retrospective study, we included 26 hemangiomas (mean size was 14 mm ± 10 mm) in 19 patients (mean age 60 ± 14 years) scanned with both gadobenate dimeglumine MRI and gadoxetic acid MRI. For each patient, we collected multiple lesion variables including location, number, size and enhancement pattern on arterial, portal venous, 3-minute and hepatobiliary phases with both gadoxetic acid and gadobenate dimeglumine. The enhancement pattern with the two contrast agents was then compared. Results The typical en…

Gadolinium DTPAMaleHepatic HemangiomaGadoxetic acidGd boptaContrast MediaGd-EOB-DTPAEnhancement patternliver030218 nuclear medicine & medical imaging03 medical and health sciencesmagnetic resonance imaging.Meglumine0302 clinical medicineImage Interpretation Computer-AssistedOrganometallic CompoundsmedicineHumansRadiology Nuclear Medicine and imagingRetrospective Studiesmedicine.diagnostic_testbusiness.industryLiver NeoplasmsMagnetic resonance imagingMiddle AgedImage EnhancementMagnetic Resonance ImagingHyperintensitygadoxetic acid030220 oncology & carcinogenesisFemaleNuclear medicinebusinessHemangiomaArterial phasemedicine.druggadobenate dimeglumine
researchProduct

Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progressi…

2020

Purpose: To determine whether hepatobiliary phase hypointensity, enhancing “capsule” and size provide prognostic information regarding the risk of progression to hepatocellular carcinoma (HCC), as well as the time to progression, of intermediate to high risk observations ≥ 10 mm with arterial phase hyperenhancement (APHE). Method: This retrospective dual-institution study included 160 LR-3 and 26 LR-4 observations measuring more than 10 mm and having APHE in 136 patients (mean age [SD], 57 [11] years old). A composite reference standard of pathologic analysis and imaging follow-up was used. The prognostic performance of hepatobiliary phase hypointensity, enhancing “capsule” and size (cut-of…

Gadolinium DTPAMalemedicine.medical_specialtyGadoxetic acidCarcinoma HepatocellularContrast MediaIndependent predictorGastroenterologyTime030218 nuclear medicine & medical imagingCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineImage Interpretation Computer-AssistedmedicineHumansRadiology Nuclear Medicine and imagingReference standardsRetrospective StudiesObserver Variationbusiness.industryTime to progressionLiver NeoplasmsMean ageGeneral MedicineMiddle AgedImage EnhancementPrognosismedicine.diseaseMagnetic Resonance ImagingLiverGadoxetic acid LI-RADS Hepatobiliary phase Hepatocellular carcinoma030220 oncology & carcinogenesisHepatocellular carcinomaDisease ProgressionHepatobiliary phaseFemalebusinessFollow-Up StudiesArterial phasemedicine.drug
researchProduct

Avoiding Pitfalls in the Interpretation of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging

2016

Gadoxetic acid is extensively used in the following 3 main clinical situations: characterization of small nodules in patients with cirrhosis, preoperative staging of liver metastases, and characterization of incidentally discovered focal liver lesions. Owing to the rapid entry of gadoxetic acid into hepatocytes, the traditional features of liver tumors are modified on magnetic resonance (MR) imaging, especially during delayed phase sequences. Thus, although the added value of gadoxetic acid for the detection and characterization of focal liver lesions is now clear, its unique pharmacokinetics as well as the presence of mimicking and atypical lesions may lead to misdiagnoses. The goal of thi…

Gadolinium DTPAmedicine.medical_specialtyGadoxetic acidRadiology Nuclear Medicine and ImagingCirrhosisContrast Mediaddc:616.0757Sensitivity and Specificity030218 nuclear medicine & medical imagingMagnetic Resonance Imaging/methods03 medical and health sciences0302 clinical medicinePreoperative stagingGadolinium DTPAImage Interpretation Computer-AssistedmedicineHumansIn patientmedicine.diagnostic_testbusiness.industryLiver DiseasesLiver DiseaseImage Interpretation Computer-Assisted/methodsMagnetic resonance imagingDelayed phasemedicine.diseaseMr imagingMagnetic Resonance ImagingLiver Diseases/diagnostic imaging030211 gastroenterology & hepatologyRadiologyNuclear medicinebusinessmedicine.drugHuman
researchProduct

Analytical Methods for the Determination of Perfume-related Substances.

2014

Las fragancias son productos químicos que desprenden un olor agradable y que se utilizan en multitud de productos de consumo a los que confieren su característico aroma. Así, se pueden encontrar en productos cosméticos de todo tipo (tales como perfumes, champús, desodorantes o jabones) y también en productos para el hogar (como detergentes, ambientadores o velas). El uso de productos cosméticos se ha incrementado progresivamente con el paso del tiempo, considerándose un indicador del progreso y bienestar de un país. El reciente Reglamento Europeo sobre productos cosméticos armoniza íntegramente las normas comunitarias a fin de lograr la libre circulación de los productos y garantizar un ele…

Gas chromatographyMolecular imprinted sorbentsMass spectrometryDispersive liquid liquid microextractionUNESCO::QUÍMICAUNESCO::QUÍMICA::Química analítica:QUÍMICA::Química analítica [UNESCO]PerfumesCosmeticsSolid phase extractionEnvironmental analysis:QUÍMICA [UNESCO]
researchProduct

Evaluation of sampling adsorbents and validation of a LC-HRMS method for determination of 28 airborne pesticides

2018

A new strategy for sampling, using a low-volume sampler, and determination of airborne pesticides by liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) has been developed. The trapping efficiency of three adsorbents (sandwich PUF-XAD2-PUF; XAD-2 and XAD-4) was tested for 33 currently used pesticides and the first adsorbent (PUF-XAD2-PUF) was selected because it presented the highest retention capacity without breakthrough. Selected PUF-XAD2-PUF had the following design: 5 g of Amberlite XAD-2 sandwiched between two cylinders of PUF (6.87 cm(3), height: 1.4 cm, diameter: 2.5 cm). A validation of the analytical methodology that includes microwave extraction with e…

Gaseous phaseChromatographyPesticide residueChemistry010401 analytical chemistryExtraction (chemistry)Air samplesAmberliteTerbuthylazine010501 environmental sciencesPesticidePirimicarb01 natural sciences0104 chemical sciencesAnalytical Chemistrychemistry.chemical_compoundAdsorbentsUHPLC-HRMSPyrimethanilPesticidesCarbofuran0105 earth and related environmental sciencesTalanta
researchProduct

Speculative and hedging activities in the European Carbon Market

2015

Abstract We explore the dynamics of the speculative and hedging activities in European futures carbon markets by using volume and open interest data. A comparison of the three phases in the European Union Emission Trading Scheme (EU ETS) reveals that (i) Phase II of the EU ETS seems to be the most speculative phase to date and (ii) the highest degree of speculative activity for every single phase occurs at the moment of listing the contracts for the first time. A seasonality analysis identifies a higher level of speculation in the first quarter of each year, related to the schedule of deadlines of the EU ETS. In addition, a time series analysis confirms that most of the speculative activity…

General EnergyFinancial economicsCarbon marketEconomicsEuropean Union Emission Trading SchemeSchedule (project management)Management Monitoring Policy and LawTime seriesListing (finance)Open interestSingle phaseSpeculationFutures contract11th International Conference on the European Energy Market (EEM14)
researchProduct